Integrin α1/β1 and α2/β1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy

International Immunology

Volumn 24, Issue 4, 2012, Pages 219-232

  Kaneko, Yoshikatsu ^a   Otsuka, Tadashi ^a   Tsuchida, Yohei ^a   Gejyo, Fumitake ^a   Narita, Ichiei ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Collagen; Dexamethasone; O glycan; Transforming growth factor; Tumor necrosis factor

Indexed keywords

COLLAGEN TYPE 4; DEXAMETHASONE; GALACTOSE; HETERODIMER; IMMUNOGLOBULIN A1; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; BASEMENT MEMBRANE; BINDING AFFINITY; BINDING KINETICS; BOWMAN CAPSULE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION; GLOMERULUS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KIDNEY BIOPSY; MESANGIUM CELL; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84859189603     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr125     Document Type: Article

References (63)

1. Donadio, J. V. and Grande, J. P. 2002. IgA nephropathy. N. Engl. J. Med. 347:738.
2. Levy, M. and Berger, J. 1988. Worldwide perspective of IgA nephropathy. Am. J. Kidney Dis. 12:340.
3. Nachman, P. H., Jennette, J. C. and Falk, R. J. 2008. Primary glomerular disease The Kidney Brenner, B. M., ed., 8th edn Saunders Elsevier, Philadelphia, PA 1024.
4. Novak, J., Vu, H. L., Novak, L. et al. 2002. Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int. 62:465.
5. Tomana, M., Matousovic, K., Julian, B. A. et al. 1997. Galactosedeficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 52:509.
6. Suzuki, H., Fan, R., Zhang, Z. et al. 2009. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J. Clin. Invest. 119:1668.
7. Launay, P., Grossetete, B., Acros-Fajardo, M. et al. 2000. Fca receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease): evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J. Exp. Med. 191:1999.
8. Kamata, T., Nogaki, F., Fagarasan, S. et al. 2000. Increased frequency of surface IgA-positive plasma cells in the intestinal lamina propria and decreased IgA excretion in hyper IgA (HIGA) mice, a murine model of IgA nephropathy with hyperserum IgA. J. Immunol. 165:1387.
9. Wang, Y., Zhao, M. H., Zhang, Y. K. et al. 2004. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin. Exp. Immunol. 136:168.
10. Komatsu, H., Fujimoto, S., Hara, S. et al. 2008. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin. J. Am. Soc. Nephrol. 3:1301.
11. Barratt, J. and Feehally, J. 2006. Treatment of IgA nephropathy. Kidney Int. 69:1934.
12. Narita, I. and Gejyo, F. 2008. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy. Clin. Exp. Nephrol. 12:332.
13. Tomino, Y., Sakai, H., Miura, M. et al. 1982. Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin. Exp. Immunol. 49:419.
14. Lomax-Smith, J. D., Zabrowarny, L. A., Howarth, G. S. et al. 1983. The immunochemical characterization of mesangial IgA deposits. Am. J. Pathol. 113:359.
15. Putnam, F. W., Liu, Y. S. V. and Low, T. L. K. 1979. Primary structure of a human IgA1 immunoglobulin. IV. Streptococcal IgA1 protease digestion, Fab and Fc fragments, and the complete amino acid sequence of the a1 heavy chain. J. Biol. Chem. 254:2865.
16. Iwase, H., Tanaka, A., Hiki, Y. et al. 1996. Estimation of the number of O-linked oligosaccharides per heavy chain of human serum IgA1 by matrix-associated laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) analysis of the hinge glycopeptide. J. Biochem. 120:393.
17. Arnold, J. N., Wormald, M. R., Sim, R. B. et al. 2007. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 25:21.
18. Mattu, T. S., Pleass, R. J., Willis, A. C. et al. 1998. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fca receptor interactions. J. Biol. Chem. 273:2260.
19. Kokubo, T., Hiki, Y., Iwase, H. et al. 1998. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J. Am. Soc. Nephrol. 9:2048.
20. Tomana, M., Novak, J., Julian, B. A. et al. 1999. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104:73.
21. Hiki, Y., Odani, H., Takahashi, M. et al. 2001. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 59:1077.
22. Moldoveanu, Z., Wyatt, R. J., Lee, J. Y. et al. 2007. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 71:1148.
23. Zhang, J. J., Xu, L. X., Zhang, Y. et al. 2006. Binding capacity of in vitro deglycosylated IgA1 to human mesangial cells. Clin. Immunol. 119:103.
24. Xu, L. X. and Zhao, M. H. 2005. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int. 68:167.
25. Gómez-Guerrero, C., Suzuki, Y. and Egido, J. 2002. The identification of IgA receptors in human mesangial cells: in the search for Eldorado. Kidney Int. 62:715.
26. Krajci, P., Solberg, R., Sandberg, M. et al. 1989. Molecular cloning of the human transmembrane secretory component (poly-Ig receptor) and its mRNA expression in human tissues. Biochem. Biophys. Res. Commun. 158:783.
27. Leung, J. C. K., Tsang, A. W. L., Chan, D. T. M. et al. 2000. Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. J. Am. Soc. Nephrol. 11:241.
28. Pacifico, F., Laviola, L., Ulianichi, L. et al. 1995. Differential expression of the asialoglycoprotein receptor in discrete brain areas, in kidney and thyroid. Biochem. Biophys. Res. Commun. 210:138.
29. Gómez-Guerrero, C., Duque, N. and Egido, J. 1998. Mesangial cells possess an asialoglycoprotein receptor with affinity for human immunoglobulin A. J. Am. Soc. Nephrol. 9:568.
30. Gómez-Guerrero, C., González, E. and Egido, J. 1993. Evidence for a specific IgA receptor in rat and human mesangial cells. J. Immunol. 151:7172.
31. Bagheri, N., Chintalacharuvu, S. R. and Emancipator, S. N. 1997. Proinflammatory cytokines regulate FcaR expression by human mesangial cells in vitro. Clin. Exp. Immunol. 107:404.
32. Diven, S. C., Caflisch, C. R., Hammond, D. K. et al. 1998. IgA induced activation of human mesangial cells: independent of FcaR1 (CD89). Kidney Int. 54:837.
33. McDonald, K. J., Cameron, A. J. M., Allen, J. M. et al. 2002. Expression of Fc a/l receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy. Biochem. Biophys. Res. Commun. 290:438.
34. Moura, I. C., Centelles, M. N., Arcos-Fajardo, M. et al. 2001. Identification of the transferrin receptor as a novel immunoglobulin (Ig) A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J. Exp. Med. 194:417.
35. Moura, I. C., Arcos-Fajardo, M., Sadaka, C. et al. 2004. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J. Am. Soc. Nephrol. 15:622.
36. Moura, I. C., Arcos-Fajardo, M., Gdoura, A. et al. 2005. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J. Am. Soc. Nephrol. 16:2667.
37. Luo, B. H., Carmen, C. V. and Springer, T. A. 2007. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25:619.
38. Adler, S. 1992. Integrin receptors in the glomerulus: potential role in glomerular injury. Am. J. Physiol. 262:F697.
39. Jin, D. K., Fish, A. J., Wayner, E. A. et al. 1996. Distribution of integrin subunits in human diabetic kidneys. J. Am. Soc. Nephrol. 7:2636.
40. Bieritz, B., Spessotto, P., Colombatti, A. et al. 2003. Role of a8 integrin in mesangial cell adhesion, migration, and proliferation. Kidney Int. 64:119.
41. Takagi, J. and Springer, T. A. 2002. Integrin activation and structural rearrangement. Immunol. Rev. 186:141.
42. Hynes, R. O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110:673.
43. Kanahara, K., Yorioka, N., Arita, M. et al. 1994. Immunohistochemical studies of extracellular matrix components and integrins in IgA nephropathy. Nephron 66:29.
44. Zhu, D., Kim, Y., Steffes, M. W. et al. 1994. Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry. Kidney Int. 45:425.
45. Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11.
46. Kerjaschki, D., Ojha, P. P., Susani, M. et al. 1989. A b1-integrin receptor for fibronectin in human kidney glomeruli. Am. J. Pathol. 134:481.
47. Simon, E. E. and McDonald, J. A. 1990. Extracellular matrix receptors in the kidney cortex. Am. J. Physiol. 259:F783.
48. Canton, A. D. 1995. Adhesion molecules in renal disease. Kidney Int. 48:1687.
49. Cederholm, B., Wieslander, J., Bygren, P. et al. 1988. Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc. Natl Acad. Sci. USA 85:4865.
50. Shinkai, Y., Karai, M., Osawa, G. et al. 1990. Antimouse laminin antibodies in IgA nephropathy and various glomerular diseases. Nephron 56:285.
51. Nakayama, H., Oite, T., Kawachi, H. et al. 1998. Comparative nephritogenicity of two monoclonal antibodies that recognize different epitopes of rat Thy-1.1 molecule. Nephron 78:453.
52. Yagi, M., Yamamoto, T., Kato, S. et al. 1998. Long-term observation of glomerulonephritis induced by multiple injections with anti-Thy-1 antibody in rats. Pathol. Int. 48:491.
53. Adler, S. G., Feld, S., Striker, L. et al. 2000. Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease. Kidney Int. 57:2084.
54. Ignotz, R. A. and Massagué, J. 1986. Transforming growth factor-b stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261: 4337.
55. Kamata, T., Muso, E., Yashiro, M. et al. 1999. Up-regulation of glomerular extracellular matrix and transforming growth factor-b expression in RF/J mice. Kidney Int. 55:864.
56. Naito, T., Nitta, K., Ozu, H. et al. 1997. Clinical assessment of the significance of platelet-derived growth factor in patients with immunoglobulin A nephropathy. J. Lab. Clin. Med. 130:63.
57. Zheng, F., Kundu, G. C., Zhang, Z. et al. 1999. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice. Nat. Med. 5:1018.
58. Coppo, R., Chiesa, M., Cirina, P. et al. 2002. In human IgA nephropathy uteroglobin does not play the role inferred from transgenic mice. Am. J. Kidney Dis. 40:495.
59. Haramaki, R., Tamaki, K., Fujisawa, M. et al. 2001. Steroid therapy and urinary transforming growth factor-b1 in IgA nephropathy. Am. J. Kidney Dis. 38:1191.
60. Baldree, L. A., Wyatt, R. J., Julian, B. A. et al. 1993. Immunoglobulin A-fibronectin aggregate levels in children and adults with immunoglobulin A nephropathy. Am. J. Kidney Dis. 22:1.
61. Chowdhury, B., Zhang, Z. and Mukherjee, A. B. 2008. Uteroglobin interacts with the heparin-binding site of fibronectin and prevents fibronectin-IgA complex formation found in IgA-nephropathy. FEBS Lett. 582:611.
62. Zhang, Z., Kundu, G. C., Yuan, C. J. et al. 1997. Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin. Science 276:1408.
63. Davin, J. C., Vecchi, M. L., Nagy, J. et al. 1991. Evidence that the interaction between circulating IgA and fibronectin is a normal process enhanced in primary IgA nephropathy. J. Clin. Immunol. 11:78.